Liliana Tuskova
Prague, PR 12808, Czech Republic
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
A murine proof-of-concept study of polatuzumab vedotin in combination with venetoclax in experimental therapy of BCL2-positive aggressive lymphomas.
Journal: Scientific reports
Published: February 13, 2026
Single Cell RNA Transcriptomics of Mantle Cell Lymphoma Reveals the Presence of Treatment-Resistant Subclones at the Time of Diagnosis.
Journal: American journal of hematology
Published: September 19, 2025
R-CHOP and R-cytarabine for transplant-ineligible MCL.
Journal: Blood advances
Published: March 04, 2025
Long-term adaptation of lymphoma cell lines to hypoxia is mediated by diverse molecular mechanisms that are targetable with specific inhibitors.
Journal: Cell death discovery
Published: August 05, 2024
Potent combination benefit of the AKT inhibitor capivasertib and the BCL-2 inhibitor venetoclax in diffuse large B cell lymphoma.
Journal: Leukemia
Published: February 15, 2024
Sequencing-based analysis of clonal evolution of 25 mantle cell lymphoma patients at diagnosis and after failure of standard immunochemotherapy.
Journal: American journal of hematology
Published: May 18, 2023
MHC II - EGFP knock-in mouse model is a suitable tool for systems and quantitative immunology.
Journal: Immunology letters
Published: June 30, 2022
Showing 1-11 of 11
Last Updated: 09/26/2026